Cargando…

5613391 SUBCLINICAL NEPHROTOXICITY IN PATIENTS WITH BETA-THALASSEMIA: ROLE OF URINARY KIDNEY INJURY MOLECULE

Detalles Bibliográficos
Autores principales:	Zakaria, M., Hassan, T.H., Nafea, O., El Gebaly, S., Salah, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112582/ http://dx.doi.org/10.1097/01.HS9.0000928364.99269.16

Ejemplares similares

5613374 ASSOCIATION BETWEEN GENOTYPE AND DISEASE COMPLICATIONS IN EGYPTIAN PATIENTS WITH BETA THALASSEMIA
por: Hassan, T.H., et al.
Publicado: (2023)

Beta thalassemia prevention in India: evaluation of socio- cultural factors
por: Chawla, Swati, et al.
Publicado: (2014)

Association between genotype and disease complications in Egyptian patients with beta thalassemia: A Cross-sectional study
por: Hassan, Tamer, et al.
Publicado: (2018)

Seroprevalence of hepatitis C virus markers in multi-transfused children with beta-thalassemia
por: Madhusudhan, Kiran, et al.
Publicado: (2012)

Diabetic mellitus type 1 in patient with beta major thalassemia (case report)
por: Intan, Eka, et al.
Publicado: (2013)

Is urinary kidney injury molecule-1 a good marker for acute kidney injury in septic shock?
por: Göschl, J, et al.
Publicado: (2012)

Acute kidney injury biomarkers offer the opportunity to reduce exposure to nephrotoxic drugs
por: Ostermann, M, et al.
Publicado: (2015)

5613511 URINARY KIDNEY INJURY MOLECULE 1 AND URINARY MONOCYTE CHEMOTACTIC PROTEIN 1 AS NOVEL BIOMARKERS FOR EARLY DIAGNOSIS OF SICKLE CELL RENAL DYSFUNCTION
por: Hussien,, et al.
Publicado: (2023)

P-054: EVALUATION OF FIRST MICROCHIP-BASED POINT-OF-CARE DEVICE FOR DIAGNOSIS OF BETA-THALASSEMIA IN INDIA
por: A., MEHTA, et al.
Publicado: (2022)

5613312 PLASMATIC MICROPARTICLES AS POTENTIAL BIOMARKERS IN THE PREVENTIVE DIAGNOSIS OF BETA THALASSEMIA
por: Chebbi, M., et al.
Publicado: (2023)

Endocrinopathies in Thalassemia major patients in Thalassemia Center Jakarta, Indonesia
por: Soesanti, Frida, et al.
Publicado: (2013)

5610611 REAL-WORLD EVIDENCE CHARACTERIZING THE BURDEN OF DISEASE IN ALPHA AND BETA THALASSEMIA PATIENTS IN THE USA: AN INTERIM ANALYSIS
por: Musallam, K.M., et al.
Publicado: (2023)

Community genetics approaches in the prevention of beta-thalassemia: towards achieving ‘Zero beta-thalassemia’ status in India
por: Rao, V R
Publicado: (2014)

Osteoporosis in Iraqi patients with thalassemia
por: AL Jadir, Salim M, et al.
Publicado: (2012)

5613463 PREVALENCE OF HEMOCHROMATOSIS HFE GENE POLYMORPHISM AMONG EGYPTIAN βTHALASSEMIA PATIENTS AND ITS RELATION TO DEVELOPMENT OF DIABETES MELLITUS
por: Zakaria, M., et al.
Publicado: (2023)

P1462: NEUROCOGNITIVE FUNCTION AND PSYCHOLOGICAL ASSESSMENT IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS: RELATION TO BRAIN IRON CONTENT
por: Adly, Amira, et al.
Publicado: (2023)

Development of small-molecule transforming growth factor beta antagonists
por: Warner, DJ, et al.
Publicado: (2006)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

S111: BRAIN PERFUSION CHANGES IN BETA-THALASSEMIA
por: Manara, R, et al.
Publicado: (2022)

Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major
por: Mahmoud, Asmaa A., et al.
Publicado: (2021)

Myocardial T1 measurement in patients with thalassemia major
por: He, Taigang, et al.
Publicado: (2009)

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
por: Kuo, K, et al.
Publicado: (2022)

P121: PREVALENCE OF VERTEBRAL COMPRESSION FRACTURE AND HYPOVITAMINOSIS D IN CHILDREN WITH THALASSEMIA MAJOR
por: Rahmartani, L, et al.
Publicado: (2022)

Diabetes mellitus and cardiac complications in thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Significant improvement of survival by T2* CMR in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2016)

Clinical and subclinical features and MEFV mutation distribution in of FMF patients’ siblings
por: Gunduz, Z, et al.
Publicado: (2015)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

P1703: ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

Could pentraxin-3 be a new marker for subclinical inflammation in familial Mediterranean fever?
por: Yüksel, S, et al.
Publicado: (2015)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

Regional myocardial contractility in Thalassemia Major by magnetic resonance tagging
por: Meloni, Antonella, et al.
Publicado: (2014)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Urinary neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury complicating circulatory shock
por: Sherif, H, et al.
Publicado: (2012)

Role of δ-Aminolevulinic Acid Dehydratase (ALAD) gene polymorphism in lead induced nephrotoxicity
por: Tiwari, Mugdha, et al.
Publicado: (2014)

Urinary Beta-2-Microglobulin and Late Nephrotoxicity in Childhood Cancer Survivors
por: Latoch, Eryk, et al.
Publicado: (2021)

Urinary and plasma NGAL levels reflect the severity of acute kidney injury
por: Bangert, K, et al.
Publicado: (2010)

5597349 VITAMIN C AND VITAMIN K2 AS RISK FACTORS FOR OSTEOPOROSIS IN CHILDREN WITH B- THALASSEMIA
por: Sherief, l.M.S., et al.
Publicado: (2023)

P1464: CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN GERMANY
por: Udeze, Chuka, et al.
Publicado: (2023)

Right ventricular wall motion abnormalities n Thalassemia Major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Subclinical cardiac abnormalities and physical function in asymptomatic elderly
por: Koh, Angela S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uu2b17t16uhd7shbd9u8pnv5be